Epsilon M&A Deal Report - Appletree CI Group
Transaction Multiples for the Valuation of Private Companies
TFS International / Appletree CI Group
No EMAT :
111944
Announced Date :
23/12/2022
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
TFS International
Target :
Appletree CI Group
Country :
Switzerland
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2013 following the merger of Clinical Investigations (founded by Dr. Gerhard Krejci in 1992) and Appletree AG (founded by Dr. Georg Mathis in 2002) , Appletree CI Group is a specialized...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 32
| Date | Acquirer | Target | Country | Multiples | See details |
| 16/05/2022 | Alliance Pharma | LGC Drug Development Solutions (DDS) | United Kingdom | * | 111924 |
| 24/01/2023 | Private Group led by Apax Partners | Porsolt | Mayenne | ** | 111888 |
Source: Epsilon Research / EMAT
